Stay updated with breaking news from Talus Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Talus Bioscience, a drug discovery company developing new treatments for cancer, inflammation, and other diseases, has announced $4.3 million in non-dilutive grant funding across three new awards.
Kitchener (PRWEB) October 04, 2022 -- Scispot, a leading lab informatics company for biostartups, has added LabSQL to its Data Science Toolkit. LabSQL is a
In addition to recent Independence Day festivities, the U.S. biotech space has other reasons to celebrate. The asthma drug developer Upstream Bio topped the ranks for the U.S.’ biggest early-stage biotech investment in June 2022, but manufacturing heavyweight National Resilience, Inc. bagged the private funding top spot with a huge Series D round.